Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries

International Journal of Radiation Oncology Biology Physics

Volumn 99, Issue 2, 2017, Pages 344-352

  Jochems, Arthur ^a   Deist, Timo M ^a   El Naqa, Issam ^b   Kessler, Marc ^b   Mayo, Chuck ^b   Reeves, Jackson ^b   Jolly, Shruti ^b   Matuszak, Martha ^b   Ten Haken, Randall ^b   van Soest, Johan ^a   Oberije, Cary ^a   Faivre Finn, Corinne ^c   Price, Gareth ^c   de Ruysscher, Dirk ^a   Lambin, Philippe ^a   Dekker, Andre ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAYESIAN NETWORKS; BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; DISEASES; DISTRIBUTED COMPUTER SYSTEMS; HOSPITAL DATA PROCESSING; HTTP; PATIENT MONITORING; RADIOTHERAPY;

AREA UNDER THE CURVES; BAYESIAN NETWORK MODELS; CONDITIONAL PROBABILITY TABLES; DISTRIBUTED LEARNING; FEDERATED DATABASES; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; SURVIVAL PREDICTION;

PATIENT TREATMENT;

AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICHIGAN; NETHERLANDS; PATIENT CODING; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; SURVIVAL PREDICTION; TASK PERFORMANCE; UNITED KINGDOM; AGE; AREA UNDER THE CURVE; BAYES THEOREM; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COHORT ANALYSIS; CONFORMAL RADIOTHERAPY; FACTUAL DATABASE; FORECASTING; KAPLAN MEIER METHOD; LEARNING; LUNG NEOPLASMS; LYMPH NODE; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VALIDATION STUDY;

ANTINEOPLASTIC AGENT;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; BAYES THEOREM; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FORECASTING; HUMANS; KAPLAN-MEIER ESTIMATE; LEARNING; LUNG NEOPLASMS; LYMPH NODES; MALE; MODELS, STATISTICAL; NEOPLASM STAGING; RADIOTHERAPY, CONFORMAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 85028706252     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2017.04.021     Document Type: Article

References (55)

1. Etheredge, L.M., A rapid-learning health system. Health Aff (Millwood) 26 (2007), w107–w118.
2. Abernethy, A.P., Etheredge, L.M., Ganz, P.A., et al. Rapid-learning system for cancer care. J Clin Oncol 28 (2010), 4268–4274.
3. Lambin, P., van Stiphout, R.G.P.M., Starmans, M.H.W., et al. Predicting outcomes in radiation oncology–multifactorial decision support systems. Nat Rev Clin Oncol 10 (2013), 27–40.
4. Lambin, P., Roelofs, E., Reymen, B., et al. “Rapid Learning health care in oncology” - an approach towards decision support systems enabling customised radiotherapy’. Radiother Oncol J Eur Soc Ther Radiol Oncol 109 (2013), 159–164.
5. Lambin, P., Petit, S.F., Aerts, H.J.W.L., et al. The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol 96 (2010), 145–152.
6. Lambin, P., Zindler, J., Vanneste, B., et al. Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine. Acta Oncol Stockh Swed 54 (2015), 1289–1300.
7. Lambin, P., Zindler, J., Vanneste, B.G.L., et al. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev, 2016.
8. Cheng, Q., Roelofs, E., Ramaekers, B.L.T., et al. Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness. Radiother Oncol J Eur Soc Ther Radiol Oncol 118 (2016), 281–285.
9. Jayasurya, K., Fung, G., Yu, S., et al. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Med Phys 37 (2010), 1401–1407.
10. Dehing-Oberije, C., De Ruysscher, D., Petit, S., et al. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 97 (2010), 455–461.
11. Vulto, A., Louwman, M., Rodrigus, P., et al. Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002. Radiother Oncol 78 (2006), 131–137.
12. Dehing-Oberije, C., De Ruysscher, D., van der Weide, H., et al. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008), 1039–1044.
13. Pfister, D.G., Johnson, D.H., Azzoli, C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003. J Clin Oncol 22 (2004), 330–353.
14. Brundage, M.D., Davies, D., Mackillop, W.J., Prognostic factors in non-small cell lung cancer: A decade of progress. Chest 122 (2002), 1037–1057.
15. Firat, S., Byhardt, R.W., Gore, E., Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 54 (2002), 357–364.
16. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer. Cochrane Database Syst Rev(2), 2000, CD002139.
17. Solan, M.J., Werner-Wasik, M., Prognostic factors in non-small cell lung cancer. Semin Surg Oncol 21 (2003), 64–73.
18. Zhao, L., West, B.T., Hayman, J.A., et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007), 103–110.
19. Werner-Wasik, M., Swann, R.S., Bradley, J., et al. Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008), 385–390.
20. Bradley, J.D., Ieumwananonthachai, N., Purdy, J.A., et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 52 (2002), 49–57.
21. Basaki, K., Abe, Y., Aoki, M., et al. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume. Int J Radiat Oncol Biol Phys 64 (2006), 449–454.
22. Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer Oxf Engl 2012:48 (1990), 441–446.
23. Anon. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. - PubMed - NCBI.
24. Leijenaar, R.T.H., Carvalho, S., Hoebers, F.J.P., et al. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol Stockh Swed 54 (2015), 1423–1429.
25. Leijenaar, R.T.H., Nalbantov, G., Carvalho, S., et al. The effect of SUV discretization in quantitative FDG-PET Radiomics: The need for standardized methodology in tumor texture analysis. Sci Rep, 5, 2015, 11075.
26. Panth, K.M., Leijenaar, R.T.H., Carvalho, S., et al. Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells. Radiother Oncol 116 (2015), 462–466.
27. Langendijk, H., de Jong, J., Wanders, R., et al. The relevance of the revised version of the international lung cancer staging system for non-small-cell lung cancer treated with radiotherapy. Clin Lung Cancer 3 (2001), 33–36.
28. Berghmans, T., Lafitte, J.J., Thiriaux, J., et al. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy. Lung Cancer 45 (2004), 339–348.
29. Collins, G.S., Reitsma, J.B., Altman, D.G., et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMC Med, 13, 2015, 1.
30. van Baardwijk, A., Wanders, S., Boersma, L., et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 28 (2010), 1380–1386.
31. Dehing-Oberije, C., Aerts, H., Yu, S., et al. Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non–Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325). Int J Radiat Oncol 81 (2011), 360–368.
32. van Baardwijk, A., Bosmans, G., Boersma, L., et al. Individualized radical radiotherapy of non–small-cell lung cancer based on normal tissue dose constraints: A feasibility study. Int J Radiat Oncol Biol Phys 71 (2008), 1394–1401.
33. Belderbos, J., Uitterhoeve, L., van Zandwijk, N., et al. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer 43 (2007), 114–121.
34. Vansteenkiste, J., Crino, L., Dooms, C., et al. 2nd ESMO Consensus Conference on Lung Cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 25 (2014), 1462–1474.
35. van Elmpt, W., Ruysscher, D.D., van der Salm, A., et al. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. Radiother Oncol 104 (2012), 67–71.
36. Lauritzen, S.L., The EM algorithm for graphical association models with missing data. Comput Stat Data Anal 19 (1995), 191–201.
37. Kuschner, K.W., Malyarenko, D.I., Cooke, W.E., et al. A Bayesian network approach to feature selection in mass spectrometry data. BMC Bioinformatics, 11, 2010, 177.
38. Jochems, A., Deist, T.M., van Soest, J., et al. Distributed learning: Developing a predictive model based on data from multiple hospitals without data leaving the hospital - A real life proof of concept. Radiother. Radiother Oncol 121 (2016), 459–467.
39. Deist, T.M., Jochems, A., van Soest, J., et al. Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT. Clin Transl Radiat Oncol 4 (2017), 24–31.
40. Druzdzel MJ. SMILE: Structural Modeling, Inference, and Learning Engine and GeNIe: A development environment for graphical decision-theoretic models. Proceeding AAAI ‘99/IAAI '99 Proceedings of the sixteenth national conference on Artificial intelligence and the eleventh Innovative applications of artificial intelligence conference innovative applications of artificial intelligence Orlando, Florida, USA — July 18 - 22, 1999. American Association for Artificial Intelligence Menlo Park, CA, USA; 1999:902-903.
41. Robin, X., Turck, N., Hainard, A., et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12, 2011, 77.
42. DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44 (1988), 837–845.
43. Therneau, T.M., Grambsch, P.M., Modeling Survival Data: Extending the Cox Model. 2000, Springer Science+Business Media, Berlin, Germany.
44. Harrington, D.P., Fleming, T.R., A class of rank test procedures for censored survival data. Biometrika 69 (1982), 553–566.
45. Dorey, F.J., Korn, E.L., Effective sample sizes for confidence intervals for survival probabilities. Stat Med 6 (1987), 679–687.
46. Bauer, D.F., Constructing confidence sets using rank statistics. J Am Stat Assoc 67 (1972), 687–690.
47. Hollander, M., Wolfe, D.A., Chicken, E., Nonparametric Statistical Methods. 2013, John Wiley & Sons, Hoboken, NJ.
48. Spirtes, P., Glymour, C., An algorithm for fast recovery of sparse causal graphs. Soc Sci Comput Rev 9 (1991), 62–72.
49. Dehing-Oberije, C., Yu, S., De Ruysscher, D., et al. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 74 (2009), 355–362.
50. Werner-Wasik, M., Scott, C., Cox, J.D., et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48 (2000), 1475–1482.
51. Komaki, R., Scott, C.B., Byhardt, R., et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 42 (1998), 263–267.
52. Bradley, J.D., Paulus, R., Komaki, R., et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): A randomised, two-by-two factorial phase 3 study. Lancet Oncol 16 (2015), 187–199.
53. Mauguen, A., Le Péchoux, C., Saunders, M.I., et al. Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-analysis. J Clin Oncol 30 (2012), 2788–2797.
54. Sesen, M.B., Nicholson, A.E., Banares-Alcantara, R., et al. Bayesian networks for clinical decision support in lung cancer care. PLoS One, 8, 2013, e82349.
55. Stacey, D., Légaré, F., Col, N.F., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev(1), 2014, CD001431.